USFDA 483 / IPCA Laboratories, Silvassa,
USFDA 483 to IPCA, Silvassa (April 2023) cites lapses in timely closure of failure investigations
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
